Similar articles

• Drug therapy in the treatment of minimal brain dysfunction.

  Saccar CL. Saccar CL. Am J Hosp Pharm. 1978 May;35(5):544-52. Am J Hosp Pharm. 1978. PMID: 26219 Review.
• An update on assessment and treatment of complex attention-deficit hyperactivity disorder.

  Hunt RD, Paguin A, Payton K. Hunt RD, et al. Pediatr Ann. 2001 Mar;30(3):162-72. doi: 10.3928/0090-4481-20010301-10. Pediatr Ann. 2001. PMID: 11257946 Review. No abstract available.
• Urinary screening for drugs in a hospital for the mentally subnormal.

  Ballinger BR, Simpson E, Stewart MJ. Ballinger BR, et al. Acta Psychiatr Scand. 1974;50(6):619-24. doi: 10.1111/j.1600-0447.1974.tb07525.x. Acta Psychiatr Scand. 1974. PMID: 4156151 No abstract available.
• Broader clinical considerations in child psychopharmacology practice.

  Safer DJ. Safer DJ. Compr Psychiatry. 1983 Nov-Dec;24(6):567-73. doi: 10.1016/0010-440x(83)90025-1. Compr Psychiatry. 1983. PMID: 6140125 Review. No abstract available.
• Psychotropic drug therapy in children and adolescents.

  Wiener JM. Wiener JM. Psychosomatics. 1982 May;23(5):488-91, 494-5. doi: 10.1016/S0033-3182(82)73381-X. Psychosomatics. 1982. PMID: 6125987 Review. No abstract available.